Lee RJ - Search Results

1

A novel protein-drug conjugate, SSH20, demonstrates significant efficacy in caveolin-1-expressing tumors.

Robb R, Kuo JC, Liu Y, Corrales-Guerrero S, Cui T, Hegazi A, Nagy G, Lee RJ, Williams TM. Robb R, et al. Among authors: lee rj. Mol Ther Oncolytics. 2021 Aug 6;22:555-564. doi: 10.1016/j.omto.2021.07.013. eCollection 2021 Sep 24. Mol Ther Oncolytics. 2021. PMID: 34553040 Free PMC article.

2

A polyethylenimine-linoleic acid conjugate for antisense oligonucleotide delivery.

Xie J, Teng L, Yang Z, Zhou C, Liu Y, Yung BC, Lee RJ. Xie J, et al. Among authors: lee rj. Biomed Res Int. 2013;2013:710502. doi: 10.1155/2013/710502. Epub 2013 Jun 1. Biomed Res Int. 2013. PMID: 23862153 Free PMC article.

3

Lipid-Albumin Nanoparticles (LAN) for Therapeutic Delivery of Antisense Oligonucleotide against HIF-1α.

Li H, Quan J, Zhang M, Yung BC, Cheng X, Liu Y, Lee YB, Ahn CH, Kim DJ, Lee RJ. Li H, et al. Among authors: lee yb, lee rj. Mol Pharm. 2016 Jul 5;13(7):2555-62. doi: 10.1021/acs.molpharmaceut.6b00363. Epub 2016 Jun 16. Mol Pharm. 2016. PMID: 27253378

4

Lipid Nanoparticles Loaded with an Antisense Oligonucleotide Gapmer Against Bcl-2 for Treatment of Lung Cancer.

Cheng X, Liu Q, Li H, Kang C, Liu Y, Guo T, Shang K, Yan C, Cheng G, Lee RJ. Cheng X, et al. Among authors: lee rj. Pharm Res. 2017 Feb;34(2):310-320. doi: 10.1007/s11095-016-2063-5. Epub 2016 Nov 28. Pharm Res. 2017. PMID: 27896589

5

Folate receptor-targeted lipid-albumin nanoparticles (F-LAN) for therapeutic delivery of an Akt1 antisense oligonucleotide.

Li H, Liu Y, Chen L, Liu Q, Qi S, Cheng X, Lee YB, Ahn CH, Kim DJ, Lee RJ. Li H, et al. Among authors: lee yb, lee rj. J Drug Target. 2018 Jun-Jul;26(5-6):466-473. doi: 10.1080/1061186X.2018.1433678. Epub 2018 Feb 8. J Drug Target. 2018. PMID: 29376449

6

Topical Lyophilized Targeted Lipid Nanoparticles in the Restoration of Skin Barrier Function following Burn Wound.

Li J, Ghatak S, El Masry MS, Das A, Liu Y, Roy S, Lee RJ, Sen CK. Li J, et al. Among authors: lee rj. Mol Ther. 2018 Sep 5;26(9):2178-2188. doi: 10.1016/j.ymthe.2018.04.021. Epub 2018 Apr 27. Mol Ther. 2018. PMID: 29802017 Free PMC article.

7

A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod.

Zhang Z, Kuo JC, Zhang C, Huang Y, Zhou Z, Lee RJ. Zhang Z, et al. Among authors: lee rj. Pharmaceutics. 2021 Dec 2;13(12):2060. doi: 10.3390/pharmaceutics13122060. Pharmaceutics. 2021. PMID: 34959344 Free PMC article.

8

CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials.

Zhang Z, Kuo JC, Yao S, Zhang C, Khan H, Lee RJ. Zhang Z, et al. Among authors: lee rj. Pharmaceutics. 2021 Dec 28;14(1):73. doi: 10.3390/pharmaceutics14010073. Pharmaceutics. 2021. PMID: 35056969 Free PMC article. Review.

9

AZD5153, a Bivalent BRD4 Inhibitor, Suppresses Hepatocarcinogenesis by Altering BRD4 Chromosomal Landscape and Modulating the Transcriptome of HCC Cells.

Lin CH, Kuo JC, Li D, Koenig AB, Pan A, Yan P, Bai XF, Lee RJ, Ghoshal K. Lin CH, et al. Among authors: lee rj. Front Cell Dev Biol. 2022 Mar 24;10:853652. doi: 10.3389/fcell.2022.853652. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35399501 Free PMC article.

10

Ivermectin Enhanced Antitumor Activity of Resiquimod in a Co-Loaded Squalene Emulsion.

Zhang Z, Kuo JC, Zhang C, Huang Y, Lee RJ. Zhang Z, et al. Among authors: lee rj. J Pharm Sci. 2022 Nov;111(11):3038-3046. doi: 10.1016/j.xphs.2022.06.005. Epub 2022 Jun 11. J Pharm Sci. 2022. PMID: 35697319

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,199 results

Search Page

Filters